What certifications does the product have?

The product has MSDS certification.

No-Rinse Pet Cleansing Foam for Effective Blackhead Removal

Name: No-Rinse Pet Cleansing Foam for Effective Blackhead Removal
Brand: Shandong Loong Nucleus Medical Technology Co., Ltd
SKU: 2137416472

Shandong, ChinaShandong Loong Nucleus Medical Technology Co., Ltd

US$1.50

1,000-1,999 Pieces

US$1.20

2,000-2,999 Pieces

US$0.95

3,000+ Pieces

Sample price:US$3.00/piece.Request sample

Product profile

Customization

Available

Type

Pet Cleaning Products

Cleaning Products Type

Pet Black Chin No-Rinse Foam

Model NO.

Pet Black Chin No-Rinse Foam

Application

Dog, Cat

Operation Type

Manual

Size

Small

Waterproof

Packaging

Box

MOQ

1000

Certificate

MSDS

Package

Custom Packaging

Manufacturer

Loongnucleus Co., Ltd.

Validity Period

3 Years

Transport Package

Box

Specification

120ml

Trademark

Loongnucleus

Origin

China

Production Capacity

100000 Pieces/Year

Key features

No-Rinse Convenience: Mild formula cleanses deeply and deodorizes without needing water rinsing.

Skin Care Ingredients: Contains Chamomile, Aloe, and Hydrolyzed Keratin to care for pet skin.

Fresh Scent Formula: Leaves a refreshing fragrance and is non-sticky after application.

Suitable for Dogs and Cats: Specifically designed for blackhead removal on dogs and cats.

Custom Packaging Available: Offers custom packaging options with a minimum order quantity of 1000.

MSDS Certified: Product holds MSDS certification ensuring safety standards.

Company profile

Shandong Loong Nucleus Medical Technology Co., Ltd

Shandong, China

CertifiedBusiness Type: Trading CompanyExport Year: 2025-05-03Nearest Port: QINGDAO)Average Response Time: ≤2.10hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): EXW, FOB, CFR, CIF, DDP, DAP, CIP

AI-Powered supplier vetting

SummaryThe supplier is a limited company involved in pharmaceutical wholesale, food sales, pharmaceutical internet information services, and veterinary drug operations. It offers Meloxicam Injection, Enrofloxacin Solution, and Cefquinome Sulfate Injection. Evidence indicates professional technical R&D capability, flexible customization, and new product activity in the past year, but no 3D design, ODM, SDK, or popular-brand OEM services. Service procedures for supplier assessment, corrective and preventive actions, and complaint handling are documented and followed. Production information is inconsistent: two production lines and 6–10 quality-control staff are reported in one slice, while another reports four total employees; manufacturing contract status is unknown and no inventory capacity is stated. No certifications, customer cases, overseas branches, warehouses, or showrooms are documented.

Supplier typeThe supplier is a limited company with stated business activities covering pharmaceutical wholesale, food sales, pharmaceutical internet information services, and veterinary drug operations. Its listed products are three veterinary pharmaceutical products, and it is not identified as part of a larger company group.

After-Sales capabilityThe supplier has written procedures and followed records for corrective and preventive actions and customer complaint handling. It has participated in an offline trade show, but has no overseas agents or branches; the evidence supports documented service processes but not a complete international after-sales network.

R&D capabilityThe supplier is identified as a professional technical supplier, reports new products within the past year, and provides flexible customization. Its capability is limited by the stated absence of 3D software design, ODM services, and an available SDK.

Customization capabilityThe supplier explicitly reports flexible customization through its R&D capability. It does not provide 3D software design, ODM services, SDK support, or OEM services for popular brands, indicating customization is available but bounded in scope.